Skip to main content
TipRanks
Go Ultimate75% OFF

SynCore Biotechnology Co., Ltd. (4192) Balance Sheet

SynCore Biotechnology Co., Ltd. Balance Sheet

SynCore Biotechnology Co., Ltd.'s total assets for Q2 2026 were NT$239.78M, a decrease of 6.32% from the previous quarter. TW:4192 total liabilities were NT$20.60M for the fiscal quarter, a 11.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Mar 24Dec 22Dec 21
NT$ 255.70MNT$ 317.80MNT$ 378.36MNT$ 436.65MNT$ 824.44M
NT$ 10.07MNT$ 23.11MNT$ 21.23MNT$ 187.64MNT$ 381.52M
NT$ 245.63MNT$ 294.69MNT$ 357.14MNT$ 249.01MNT$ 442.92M

Currency in TWD

SynCore Biotechnology Co., Ltd. Liabilities to Assets

0400M800M1.2B0 %20 %40 %60 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets